Teleflex Inc
TFX116.270USD
+0.380+0.33%
Market hours （ET）Quotes delayed by 15 min
5.14BMarket Cap
34.40P/E TTM
More Details of Teleflex Inc Company
Teleflex Incorporated is a global provider of medical technology products. The Company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The Company has four segments: Americas, EMEA (Europe, the Middle East and Africa), Asia (Asia Pacific) and OEM (Original Equipment Manufacturer and Development Services). OEM segment designs, manufactures and supplies devices and instruments for other medical device manufacturers. Its OEM division includes the TFX Medical OEM, TFX OEM, Deknatel and HPC Medical brands, provides custom extrusions, micro-diameter film-cast tubing, diagnostic and interventional catheters, balloons and balloon catheters, film-insulated fine wire, coated mandrel wire, conductors, sheath/dilator introducers, and others. Its other brands include Arrow, LMA, Pilling, QuikClot, Rusch, UroLift, Weck and Barrigel.
Company Info
Ticker SymbolTFX
Company nameTeleflex Inc
IPO dateMar 17, 1980
CEOMr. Liam J. Kelly
Number of employees14100
Security typeOrdinary Share
Fiscal year-endMar 17
Address550 E Swedesford Rd
CityWAYNE
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code19087
Phone16102256800
Websitehttps://www.teleflex.com/usa/en/#
Ticker SymbolTFX
IPO dateMar 17, 1980
CEOMr. Liam J. Kelly
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
49.49K
+19.61%
Mr. Cameron P. Hicks
Mr. Cameron P. Hicks
Corporate Vice President - Human Resources and Communications
Corporate Vice President - Human Resources and Communications
10.38K
+12.60%
Dr. Stephen K. Klasko, M.D.
Dr. Stephen K. Klasko, M.D.
Lead Independent Director
Lead Independent Director
10.06K
+15.59%
Mr. Stuart Allen (Stu) Randle
Mr. Stuart Allen (Stu) Randle
Independent Director
Independent Director
9.22K
+12.86%
Mr. Andrew A. (Andy) Krakauer
Mr. Andrew A. (Andy) Krakauer
Independent Director
Independent Director
5.54K
+23.40%
Ms. Gretchen R. Haggerty
Ms. Gretchen R. Haggerty
Independent Director
Independent Director
5.16K
+25.60%
Mr. John C. Heinmiller
Mr. John C. Heinmiller
Independent Director
Independent Director
4.39K
+31.47%
Ms. Neena M. Patil, J.D.
Ms. Neena M. Patil, J.D.
Independent Director
Independent Director
1.98K
+113.50%
Dr. Jaewon Ryu, M.D., J.D.
Dr. Jaewon Ryu, M.D., J.D.
Independent Director
Independent Director
1.58K
+199.43%
Mr. John R. Deren
Mr. John R. Deren
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
49.49K
+19.61%
Mr. Cameron P. Hicks
Mr. Cameron P. Hicks
Corporate Vice President - Human Resources and Communications
Corporate Vice President - Human Resources and Communications
10.38K
+12.60%
Dr. Stephen K. Klasko, M.D.
Dr. Stephen K. Klasko, M.D.
Lead Independent Director
Lead Independent Director
10.06K
+15.59%
Mr. Stuart Allen (Stu) Randle
Mr. Stuart Allen (Stu) Randle
Independent Director
Independent Director
9.22K
+12.86%
Mr. Andrew A. (Andy) Krakauer
Mr. Andrew A. (Andy) Krakauer
Independent Director
Independent Director
5.54K
+23.40%
Ms. Gretchen R. Haggerty
Ms. Gretchen R. Haggerty
Independent Director
Independent Director
5.16K
+25.60%
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Vascular access
182.37M
26.03%
Interventional
137.56M
19.63%
Surgical
105.78M
15.10%
Anesthesia
86.59M
12.36%
Interventional urology
70.97M
10.13%
Other
117.40M
16.75%
By RegionUSD
Name
Revenue
Proportion
Americas
475.72M
67.90%
EMEA
151.16M
21.57%
Asia Pacific
73.79M
10.53%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Vascular access
182.37M
26.03%
Interventional
137.56M
19.63%
Surgical
105.78M
15.10%
Anesthesia
86.59M
12.36%
Interventional urology
70.97M
10.13%
Other
117.40M
16.75%
Shareholding Stats
Updated: Sat, Jul 26
Updated: Sat, Jul 26
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
T. Rowe Price Investment Management, Inc.
14.07%
BlackRock Institutional Trust Company, N.A.
12.12%
The Vanguard Group, Inc.
11.47%
Janus Henderson Investors
9.79%
UBS Financial Services, Inc.
7.50%
Other
45.06%
Shareholders
Shareholders
Proportion
T. Rowe Price Investment Management, Inc.
14.07%
BlackRock Institutional Trust Company, N.A.
12.12%
The Vanguard Group, Inc.
11.47%
Janus Henderson Investors
9.79%
UBS Financial Services, Inc.
7.50%
Other
45.06%
Shareholder Types
Shareholders
Proportion
Investment Advisor
67.05%
Investment Advisor/Hedge Fund
28.93%
Hedge Fund
7.40%
Research Firm
2.30%
Pension Fund
1.73%
Sovereign Wealth Fund
1.38%
Bank and Trust
0.40%
Individual Investor
0.33%
Family Office
0.09%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
1156
48.39M
109.50%
-826.33K
2025Q1
1189
48.85M
110.52%
-721.30K
2024Q4
1180
47.47M
102.37%
-260.40K
2024Q3
1150
46.34M
98.36%
-1.83M
2024Q2
1147
46.98M
99.75%
-268.09K
2024Q1
1153
46.02M
97.70%
-1.89M
2023Q4
1170
46.05M
97.91%
-2.57M
2023Q3
1173
45.95M
97.77%
-3.19M
2023Q2
1201
46.87M
99.79%
-2.79M
2023Q1
1212
46.93M
99.93%
-1.70M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
T. Rowe Price Investment Management, Inc.
6.22M
14.07%
+43.64K
+0.71%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
5.36M
12.12%
+2.71M
+102.18%
Mar 31, 2025
The Vanguard Group, Inc.
5.07M
11.47%
-456.07K
-8.26%
Mar 31, 2025
Janus Henderson Investors
4.33M
9.79%
-933.48K
-17.75%
Mar 31, 2025
UBS Financial Services, Inc.
3.31M
7.5%
+3.09M
+1413.63%
Mar 31, 2025
Atlanta Capital Management Company, L.L.C.
2.78M
6.29%
+73.14K
+2.70%
Mar 31, 2025
State Street Global Advisors (US)
1.53M
3.46%
-531.22K
-25.79%
Mar 31, 2025
Cooke & Bieler, L.P.
1.06M
2.39%
-21.03K
-1.95%
Mar 31, 2025
Geode Capital Management, L.L.C.
1.02M
2.31%
-119.68K
-10.51%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
867.86K
1.96%
+355.72K
+69.46%
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
Invesco S&P SmallCap Health Care ETF
3.74%
SPDR S&P Health Care Equipment ETF
1.76%
First Trust Indxx Medical Devices ETF
1.67%
Distillate Small/Mid Cash Flow ETF
0.99%
SPDR S&P 600 Small Cap Value ETF
0.82%
iShares S&P Small-Cap 600 Value ETF
0.82%
iShares MSCI USA Small-Cap Min Vol Factor ETF
0.75%
VictoryShares Small Cap Free Cash Flow ETF
0.68%
iShares U.S. Medical Devices ETF
0.59%
SPDR S&P SmallCap 600 ESG ETF
0.55%
View more
Invesco S&P SmallCap Health Care ETF
Proportion3.74%
SPDR S&P Health Care Equipment ETF
Proportion1.76%
First Trust Indxx Medical Devices ETF
Proportion1.67%
Distillate Small/Mid Cash Flow ETF
Proportion0.99%
SPDR S&P 600 Small Cap Value ETF
Proportion0.82%
iShares S&P Small-Cap 600 Value ETF
Proportion0.82%
iShares MSCI USA Small-Cap Min Vol Factor ETF
Proportion0.75%
VictoryShares Small Cap Free Cash Flow ETF
Proportion0.68%
iShares U.S. Medical Devices ETF
Proportion0.59%
SPDR S&P SmallCap 600 ESG ETF
Proportion0.55%
Dividend
A total of
318.10M
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Feb 27, 2025
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Mar 17, 2025 going ex on Mar 07, 2025
Mar 07, 2025
Mar 17, 2025
Mar 07, 2025
Oct 31, 2024
TFX.NB Final Cash Dividend of gross USD 0.34 paid on Dec 16, 2024 going ex on Nov 15, 2024
Nov 15, 2024
Dec 16, 2024
Nov 15, 2024
Aug 01, 2024
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Sep 16, 2024 going ex on Aug 15, 2024
Aug 15, 2024
Sep 16, 2024
Aug 15, 2024
May 06, 2024
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Jun 14, 2024 going ex on May 14, 2024
May 15, 2024
Jun 14, 2024
May 14, 2024
Feb 22, 2024
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Mar 15, 2024 going ex on Feb 29, 2024
Mar 01, 2024
Mar 15, 2024
Feb 29, 2024
Nov 02, 2023
TFX.NB Final Cash Dividend of gross USD 0.34 paid on Dec 15, 2023 going ex on Nov 14, 2023
Nov 15, 2023
Dec 15, 2023
Nov 14, 2023
Aug 03, 2023
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Sep 15, 2023 going ex on Aug 14, 2023
Aug 15, 2023
Sep 15, 2023
Aug 14, 2023
May 08, 2023
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Jun 15, 2023 going ex on May 12, 2023
May 15, 2023
Jun 15, 2023
May 12, 2023
Feb 23, 2023
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Mar 15, 2023 going ex on Mar 02, 2023
Mar 03, 2023
Mar 15, 2023
Mar 02, 2023
Oct 27, 2022
TFX.NB Final Cash Dividend of gross USD 0.34 paid on Dec 15, 2022 going ex on Nov 14, 2022
Nov 15, 2022
Dec 15, 2022
Nov 14, 2022
View more
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
